These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20929063)

  • 1. [Warfarin therapy and hemarthrosis].
    Kuperman A; Brenner B
    Harefuah; 2010 May; 149(5):268-9, 337. PubMed ID: 20929063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
    Francis CW; Berkowitz SD; Comp PC; Lieberman JR; Ginsberg JS; Paiement G; Peters GR; Roth AW; McElhattan J; Colwell CW;
    N Engl J Med; 2003 Oct; 349(18):1703-12. PubMed ID: 14585938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destructive monarticular arthritis secondary to anticoagulant therapy.
    Riley SA; Spencer GE
    Clin Orthop Relat Res; 1987 Oct; (223):247-51. PubMed ID: 3652583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemarthroses complicating anticoagulant therapy (heparin, oral anticoagulants)].
    Gerster JC; Wauters JP; Waldburger M; Saudan Y
    Schweiz Med Wochenschr; 1977 Aug; 107(33):1170-2. PubMed ID: 897653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of anticoagulant therapy for patients with venous thromboembolism.
    Garcia D
    Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism.
    Spaulding C
    J Fam Pract; 1995 Dec; 41(6):604-5. PubMed ID: 7500073
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of warfarin-related major bleeding in patients with recurrent venous thromboembolism.
    Prandoni P; Lensing AW; Bagatella P; Simioni P; Girolami A
    Thromb Haemost; 1999 Jul; 82(1):158-9. PubMed ID: 10456478
    [No Abstract]   [Full Text] [Related]  

  • 10. Low dose.
    Shrivastava S; Ridker PM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):880-1. PubMed ID: 16491634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemarthrosis associated with sodium warfarin.
    Jaffer AM; Schmid FR
    J Rheumatol; 1977; 4(2):215-7. PubMed ID: 881700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigmented villonodular synovitis of the ankle occurring in a patient on anticoagulation therapy.
    Pearse EO; Klass B; Bendall SP
    J Surg Orthop Adv; 2004; 13(4):217-9. PubMed ID: 15691183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating warfarin therapy: 5 mg versus 10 mg.
    Eckhoff CD; Didomenico RJ; Shapiro NL
    Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.
    Bohm NM; Crosby B
    Ann Pharmacother; 2012; 46(7-8):e19. PubMed ID: 22764328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
    Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.